A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib.
We report a case of a 66-year-old Taiwanese female patient with situs ambiguus diagnosed of pancreatic head cancer. She was treated with gemcitabine and erlotinib and remained in stable disease on follow-up imaging studies. Situs ambiguus is a rare disease and reports of such patients with cancer have rarely been reported in the literature. Our case illustrates that standard chemotherapy in this group of patients may be undergone with promising results.
Lin
Po-Chou
PC
National Yang-Ming University School of Medicine, Taiwan, Republic of China.
Lai
Jiun-I
JI
Tzeng
Cheng-Hwai
CH
Wang
Wei-Shu
WS
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D010190:Pancreatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D011799:Quinazolines / Q000008:administration & dosage; D012857:Situs Inversus / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D000093542:Gemcitabine
D011799:Quinazolines; D003841:Deoxycytidine; D000069347:Erlotinib Hydrochloride; D000093542:Gemcitabine